Hyaluronic Acid / Viscosupplementation
Draft Report Published: March 19, 2010
Public Comment Period: March 19 - April 2, 2010
Final Report Published: April 16, 2010
HTCC Public Meeting: May 14, 2010

Topic Summary

Concerns about safety, efficacy and costs regarding of hyaluronic acid (HA) / viscosupplementation. HA is used as an intra-articular treatment for relief of pain, associated with osteoarthritis (OA), with the potential for disease modification through improvement of synovial fluid quality and/or quantity. HA for intra-articular injected has been approved by the FDA for use in patients with OA of the knee who have not responded to exercise, physical therapy, and nonprescription analgesics.

Primary Criteria Ranking

Safety = Low
Efficacy = Medium
Cost = High